Alpha particles more promising than toxins? Jacques BarbetMichel ChérelJean-François Chatal Editorial Commentary 20 March 2010 Pages: 849 - 850
In vitro experimental 211At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin Thorsten PetrichZekiye KorkmazWolfram H. Knapp Original Article 27 January 2010 Pages: 851 - 861
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) Massimiliano PacilioMargherita BettiFrancesco Scopinaro Original Article 13 January 2010 Pages: 862 - 873
Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data Tuula TolvanenTimo Yli-KerttulaAnne Roivainen Original Article 13 January 2010 Pages: 874 - 883
Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer Walter JentzenRobert F. HobbsAndreas Bockisch Original Article 13 January 2010 Pages: 884 - 895
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience Frederik A. VerburgHeribert HänscheidMarkus Luster Original Article 24 December 2009 Pages: 896 - 903
Efficacy of using a standard activity of 131I-MIBG therapy in patients with disseminated neuroendocrine tumours Shaunak NavalkissoorDona M. AlhashimiJohn R. Buscombe Original Article 17 December 2009 Pages: 904 - 912
The new FDG brain revolution: the neurovascular unit and the default network Stelvio SestiniAntonio CastagnoliLuigi Mansi Editorial 22 December 2009 Pages: 913 - 916
Approaches to quantify radioligands that wash out slowly from target organs Jussi HirvonenGarth E. TerryRobert B. Innis Editorial Commentary 01 April 2010 Pages: 917 - 919
Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain Sandra Marina Sanabria-BohórquezTerence G. HamillKoen Van Laere Original Article 24 December 2009 Pages: 920 - 933
In vivo detection of prion amyloid plaques using [11C]BF-227 PET Nobuyuki OkamuraYusei ShigaKatsumi Doh-ura Original Article 17 December 2009 Pages: 934 - 941
Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET Claudia KuntnerJens P. BankstahlOliver Langer Original Article 17 December 2009 Pages: 942 - 953
Protective effects of repetitive transcranial magnetic stimulation in a rat model of transient cerebral ischaemia: a microPET study Feng GaoShuang WangHong Zhang Original Article 27 January 2010 Pages: 954 - 961
In vivo imaging of neuroinflammation: a comparative study between [18F]PBR111, [11C]CLINME and [11C]PK11195 in an acute rodent model Nadja Van CampRaphael BoisgardBertrand Tavitian Original Article 13 January 2010 Pages: 962 - 972
Hybrid versus fusion imaging: are we moving forward judiciously? Luca GiovanellaGiovanni Lucignani Editorial Commentary 10 February 2010 Pages: 973 - 979
Integrating imaging modalities: what makes sense from a workflow perspective? Gustav K. von SchulthessCyrill Burger Special Contribution 06 February 2010 Pages: 980 - 990
High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications Nicolas AideCédric DesmontsRodney J. Hicks Original Article 27 January 2010 Pages: 991 - 1001
Use of 99mTc-MDP SPECT for assessment of mandibular growth: development of normal values Frederic H. FaheyZachary R. AbramsonS. Ted Treves Original Article 22 December 2009 Pages: 1002 - 1010
Clearance of the high intestinal 18F-FDG uptake associated with metformin after stopping the drug Tamer ÖzülkerFiliz ÖzülkerTevfik Özpaçacı Original Article 27 January 2010 Pages: 1011 - 1017
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues Edgar J. RollemanMarleen MelisMarion de Jong Review Article 14 November 2009 Pages: 1018 - 1031
Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours Giovanni LucignaniSteven M. Larson FOCUS ON... 30 March 2010 Pages: 1032 - 1038
Can an undetectable value of TG and a negative neck ultrasound study be considered reliable methods to assess the completeness of thyroid ablation? Massimo SalvatoriGermano PerottiMassimo Eugenio Dottorini Letter to the Editor 23 March 2010 Pages: 1039 - 1040
Reply to: Can an undetectable value of TG and a negative neck ultrasound study be considered reliable methods to assess the completeness of thyroid ablation? Glenn D. FluxMasud HaqClive L. Harmer Letter to the Editor 23 March 2010 Pages: 1041 - 1042
Torsten B. Moeller and Emil Reif (eds). 2009. Pocket atlas of radiographic positioning Luigi Mansi Book Review 20 March 2010 Pages: 1043 - 1044
Erratum to: Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain Sandra Marina Sanabria-BohórquezTerence G. HamillKoen Van Laere Erratum 04 February 2010 Pages: 1045 - 1046
High-resolution 18F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis Abhijit J. ChaudhariSpencer L. BowenRamsey D. Badawi Image of the Month Open access 30 January 2010 Pages: 1047 - 1047
Extrastriatal uptake on 123I-ioflupane brain SPECT Gaetane CeulemansDouwe VerdriesHendrik Everaert Image of the Month 04 February 2010 Pages: 1048 - 1048
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals Philip ElsingaSergio ToddeThe Radiopharmacy Committee of the EANM Guidelines Open access 20 March 2010 Pages: 1049 - 1062